CAS 1252594-99-2

ETP-46321

Description:

ETP-46321, identified by its CAS number 1252594-99-2, is a chemical compound that falls within the category of small molecules, often utilized in pharmaceutical research and development. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds like ETP-46321 are typically characterized by their potential therapeutic applications, including their mechanism of action, solubility, stability, and toxicity profiles. Researchers often investigate such compounds for their efficacy in targeting specific biological pathways or diseases. The development and characterization of ETP-46321 would involve rigorous testing, including in vitro and in vivo studies, to assess its pharmacokinetics and pharmacodynamics. As with many chemical substances, safety data and regulatory compliance are crucial for its use in any applications, particularly in the pharmaceutical industry. For detailed and specific information, consulting scientific literature or proprietary databases would be necessary.

ETP-46321

CAS: 1252594-99-2

ETP-46321

Purity: ≥98%

Molecular weight: 473.55g/mol

Ref: 54-BUP08918

ETP-46321

CAS: 1252594-99-2

ETP-46321 is an effective and orally bioavailable PI3Kα/PI3Kδ inhibitor (Ki: 2.3/14.2 nM).

Formula: C₂₀H₂₇N₉O₃S

Purity: 99.8%

Color and Shape: Solid

Molecular weight: 473.55

Ref: TM-TQ0229

ETP-46321

CAS: 1252594-99-2

ETP-46321 is an imidazopyrazine that inhibits the activity of the enzyme phosphatase 2A, which is involved in a number of signaling pathways. It has been shown to activate IL-17a, and inhibit tumor growth in mice. ETP-46321 also has pharmacokinetic properties that are suited for oral administration. The drug binds to the catalytic subunit of protein phosphatase 2A (PP2Ac) and prevents it from dephosphorylating its substrate, thereby inhibiting its enzymatic activity. This inhibition leads to increased levels of activated PP2Ac, which in turn leads to the activation and proliferation of cells. ETP-46321 has shown efficacy against cancer cells in vitro and can be used as an immunosuppressant for autoimmune diseases due to its ability to inhibit IL-17a production by T cells.

Formula: C₂₀H₂₇N₉O₃S

Purity: Min. 95%

Molecular weight: 473.55 g/mol

Ref: 3D-CAC59499